Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Broadly neutralizing antibodies (bNAbs) are promising as potential therapies targeting HIV-1 but their overall antiviral activity remains to be fully elucidated. Here the authors evaluate the ability of a panel of bNAbs to trigger antibody-dependent cellular cytotoxicity and identify the most effect...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10844 |